FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4288049679> ?p ?o ?g. }

• W4288049679 endingPage "4104" @default.
• W4288049679 startingPage "4092" @default.
• W4288049679 abstract "Determine whether specific CTNNB1 or APC mutations in patients with desmoid tumor were associated with differences in clinical responses to systemic treatments.We established a multi-institutional dataset of previously treated patients with desmoid tumor across four U.S. sarcoma centers, including demographic and clinicopathologic characteristics, treatment regimens, and clinical and radiographic responses. CTNNB1 or APC mutation status was determined from prior pathology records, or archival tissue was requested and analyzed by Sanger sequencing and/or next-generation sequencing. Evaluable patients with mutation results were analyzed to determine clinical progression-free survival (cPFS), RECIST 1.1 PFS (rPFS), time to next treatment (TTNT), and overall survival (OS). Kaplan-Meier analysis and Cox proportional hazards regression were performed to identify differences in cPFS, rPFS, TTNT, and OS by mutation subtype, desmoid tumor location, and treatment regimen.A total of 259 evaluable patients were analyzed for at least one of the survival outcomes, with 177 patients having mutation data. First- and second-line cPFS, rPFS, and TTNT were not significantly affected by mutation subtype; however, APC-mutant desmoid tumors demonstrated nonstatistically significant inferior outcomes. Extremity/trunk desmoid tumor location and treatment with doxorubicin-based, methotrexate/vinca alkaloids and sorafenib regimens were associated with better clinical outcomes compared with surgery or other therapies, including estrogen-receptor blockade and imatinib. OS was significantly worse with APC or CTNNB1 negative/other mutations.Mutation subtype did not affect responses to specific systemic therapies. APC mutations and nonextremity desmoid tumor locations remain prognostic for worse outcomes, and earlier initiation of systemic therapy for these higher-risk desmoid tumors should be prospectively evaluated. See related commentary by Greene and Van Tine, p. 3911." @default.
• W4288049679 created "2022-07-27" @default.
• W4288049679 creator A5000055976 @default.
• W4288049679 creator A5004418792 @default.
• W4288049679 creator A5004799762 @default.
• W4288049679 creator A5009886411 @default.
• W4288049679 creator A5014985967 @default.
• W4288049679 creator A5017114190 @default.
• W4288049679 creator A5023475820 @default.
• W4288049679 creator A5024913801 @default.
• W4288049679 creator A5025985136 @default.
• W4288049679 creator A5026958401 @default.
• W4288049679 creator A5031620383 @default.
• W4288049679 creator A5033777229 @default.
• W4288049679 creator A5039859499 @default.
• W4288049679 creator A5040242676 @default.
• W4288049679 creator A5047381478 @default.
• W4288049679 creator A5048158207 @default.
• W4288049679 creator A5048398844 @default.
• W4288049679 creator A5050445982 @default.
• W4288049679 creator A5054595254 @default.
• W4288049679 creator A5063346173 @default.
• W4288049679 creator A5063576155 @default.
• W4288049679 creator A5068677359 @default.
• W4288049679 creator A5071575774 @default.
• W4288049679 creator A5079960723 @default.
• W4288049679 creator A5081786747 @default.
• W4288049679 creator A5087234749 @default.
• W4288049679 creator A5089734812 @default.
• W4288049679 date "2022-02-18" @default.
• W4288049679 modified "2023-09-30" @default.
• W4288049679 title "Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in <i>CTNNB1</i> or <i>APC</i>: A Multi-institutional Retrospective Study" @default.
• W4288049679 cites W1547479894 @default.
• W4288049679 cites W1602160127 @default.
• W4288049679 cites W1768058676 @default.
• W4288049679 cites W1798211820 @default.
• W4288049679 cites W1914631366 @default.
• W4288049679 cites W1970852339 @default.
• W4288049679 cites W1977172662 @default.
• W4288049679 cites W1979760132 @default.
• W4288049679 cites W1985382722 @default.
• W4288049679 cites W1989604862 @default.
• W4288049679 cites W1995733868 @default.
• W4288049679 cites W2003852692 @default.
• W4288049679 cites W2025402368 @default.
• W4288049679 cites W2036149289 @default.
• W4288049679 cites W2045479207 @default.
• W4288049679 cites W2046792469 @default.
• W4288049679 cites W2046959912 @default.
• W4288049679 cites W2070102209 @default.
• W4288049679 cites W2073052893 @default.
• W4288049679 cites W2074160759 @default.
• W4288049679 cites W2078166412 @default.
• W4288049679 cites W2090567495 @default.
• W4288049679 cites W2094141932 @default.
• W4288049679 cites W2116318030 @default.
• W4288049679 cites W2124819146 @default.
• W4288049679 cites W2140004941 @default.
• W4288049679 cites W2149566020 @default.
• W4288049679 cites W2152015156 @default.
• W4288049679 cites W2173051913 @default.
• W4288049679 cites W2258278932 @default.
• W4288049679 cites W2334592612 @default.
• W4288049679 cites W2498794351 @default.
• W4288049679 cites W2597641129 @default.
• W4288049679 cites W2963740442 @default.
• W4288049679 cites W3004209283 @default.
• W4288049679 cites W3046362099 @default.
• W4288049679 cites W3084419403 @default.
• W4288049679 cites W3091075868 @default.
• W4288049679 cites W3118521520 @default.
• W4288049679 cites W3177377818 @default.
• W4288049679 doi "https://doi.org/10.1158/1078-0432.ccr-21-4504" @default.
• W4288049679 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35180772" @default.
• W4288049679 hasPublicationYear "2022" @default.
• W4288049679 type Work @default.
• W4288049679 citedByCount "6" @default.
• W4288049679 countsByYear W42880496792022 @default.
• W4288049679 countsByYear W42880496792023 @default.
• W4288049679 crossrefType "journal-article" @default.
• W4288049679 hasAuthorship W4288049679A5000055976 @default.
• W4288049679 hasAuthorship W4288049679A5004418792 @default.
• W4288049679 hasAuthorship W4288049679A5004799762 @default.
• W4288049679 hasAuthorship W4288049679A5009886411 @default.
• W4288049679 hasAuthorship W4288049679A5014985967 @default.
• W4288049679 hasAuthorship W4288049679A5017114190 @default.
• W4288049679 hasAuthorship W4288049679A5023475820 @default.
• W4288049679 hasAuthorship W4288049679A5024913801 @default.
• W4288049679 hasAuthorship W4288049679A5025985136 @default.
• W4288049679 hasAuthorship W4288049679A5026958401 @default.
• W4288049679 hasAuthorship W4288049679A5031620383 @default.
• W4288049679 hasAuthorship W4288049679A5033777229 @default.
• W4288049679 hasAuthorship W4288049679A5039859499 @default.
• W4288049679 hasAuthorship W4288049679A5040242676 @default.
• W4288049679 hasAuthorship W4288049679A5047381478 @default.
• W4288049679 hasAuthorship W4288049679A5048158207 @default.
• W4288049679 hasAuthorship W4288049679A5048398844 @default.
• W4288049679 hasAuthorship W4288049679A5050445982 @default.

• next